Application of Combined PGT-A and PGT-M for Reproductive Management in a Couple Carrying GCDH Mutations with Prior Affected Offspring: A Rare Case Report

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Case A 31-year-old woman with secondary subfertility, four recurrent pregnancy losses, and one previous live-born child affected with glutaric acidemia type I (GA-I) was evaluated. Genetic testing confirmed that both partners were heterozygous carriers of pathogenic GCDH variants (c.769C>T in exon 8 and c.1204C>T in exon 11, NM_000159.4). Given the high recurrence risk, the couple underwent in vitro fertilization with intracytoplasmic sperm injection, blastocyst culture, trophectoderm biopsy, and combined preimplantation genetic testing for aneuploidy (PGT-A) and monogenic disease (PGT-M). Outcome Three blastocysts were biopsied. One embryo exhibited segmental aneuploidy of chromosome 16 and was excluded. A second embryo was euploid and wild-type for both GCDH variants, classified as genetically normal. The third was euploid but heterozygous for c.769C>T, consistent with carrier status. The genetically normal embryo was selected for frozen embryo transfer, resulting in a singleton intrauterine pregnancy. Non-invasive prenatal testing at 12 weeks showed a normal chromosomal profile. At the time of report, the pregnancy is ongoing at 20 weeks without complications. Conclusion This case demonstrates that combined PGT-A and PGT-M can effectively prevent recurrence of GA-I, improve reproductive outcomes, and provide a valuable option for couples with monogenic disorders and recurrent pregnancy loss.

Article activity feed